International edition Finance & trade

Thursday, 19 November 2026

National Trade News

Independent coverage of global markets, trade and finance

Finance & markets

CEO turned informant: How the FDA built a case against executives promising cheap medications

National Trade News capital-markets note (2026-11-18): The FDA's unprecedented criminal case against an alternative funding program hinged on the cooperation of a peer CEO, according to a court record. Primary source: original at CNBC Top News (cnbc.com).

· CNBC Top News

CEO turned informant: How the FDA built a case against executives promising cheap medications

The FDA's unprecedented criminal case against an alternative funding program hinged on the cooperation of a peer CEO, according to a court record.

Read at source